CLINICAL TRIALS PROFILE FOR ANAPROX DS

All Clinical Trials for Anaprox Ds

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00688961 ↗	Effects of Omacor and Aspirin on Platelet Function	Completed	Sanford Research	Early Phase 1	2007-06-01	Omacor (now Lovaza) is a pharmaceutical omega-3 fatty acid product. Omega-3 fatty acids can affect blood clotting by altering the function of the blood platelets. Aspirin can do the same. The purpose of this study is to determine the individual and combined effects of these two agents on platelet function using a whole blood method.
NCT00778193 ↗	Effect of Naproxen, Aspirin, Celecoxib, or Clopidogrel on the Healing of Stomach and Intestinal Ulcers	Completed	Research Associates of New York, LLP	Phase 4	2007-10-01	Gastroduodenal ulcers are extremely common in the community today. Though much has been written and observed concerning how ulcers form, not much has been described in the human model concerning how these ulcers heal. As numerous patients already suffer from gastrointestinal ulcers, further clarification of ulcer healing would be valuable in the treatment and management of these patients. The goal of this study is to investigate the effects of naproxen, aspirin, celecoxib, and clopidogrel on biopsy-induced gastroduodenal lesions in order to elucidate the mechanisms of ulcer healing. This single site, single-blind, randomized, placebo-controlled, one-week prospective study will examine ulcer healing through endoscopic, immunohistologic, and molecular PCR modalities.
NCT01052129 ↗	Bioequivalence Study of Naproxen Sodium 550 mg Tablets Under Fasting Condition	Completed	Dr. Reddy's Laboratories Limited	Phase 1	2006-05-01	An open label randomised, two-treatment, two-period, two-sequence, single-dose, crossover, comparative bioequivalence study.
NCT01052792 ↗	Bioequivalence Study of Naproxen Sodium 550 mg Tablets Under Fed Conditions	Completed	Dr. Reddy's Laboratories Limited	Phase 1	2006-05-01	An open label randomised, two-treatment,two-period, two-sequence, single-dose, crossover, comparative bioequivalence study.

Clinical Trial Conditions for Anaprox Ds

Condition Name

Condition Name for Anaprox Ds
Intervention	Trials
Healthy	3
Acute Pain	2
Chronic Low Back Pain	2
Chronic Low-back Pain	1

Condition MeSH

Condition MeSH for Anaprox Ds
Intervention	Trials
Back Pain	4
Low Back Pain	3
Acute Pain	2
Immune Reconstitution Inflammatory Syndrome	1

Clinical Trial Locations for Anaprox Ds

Trials by Country

Trials by Country for Anaprox Ds
Location	Trials
United States	7
India	2
Thailand	1

Trials by US State

Trials by US State for Anaprox Ds
Location	Trials
Illinois	5
New York	1
South Dakota	1

Clinical Trial Progress for Anaprox Ds

Clinical Trial Phase

Clinical Trial Phase for Anaprox Ds
Clinical Trial Phase	Trials
Phase 4	5
Phase 2/Phase 3	1
Phase 2	4

Clinical Trial Status

Clinical Trial Status for Anaprox Ds
Clinical Trial Phase	Trials
Completed	6
Withdrawn	3
Unknown status	2

Clinical Trial Sponsors for Anaprox Ds

Sponsor Name

Sponsor Name for Anaprox Ds
Sponsor	Trials
National Institutes of Health (NIH)	6
Northwestern University	5
National Institute of Dental and Craniofacial Research (NIDCR)	2

Sponsor Type

Sponsor Type for Anaprox Ds
Sponsor	Trials
Other	14
NIH	10
Industry	5